🔎 Trials Near Me

Home › Stuttering › NCT07389694

Using Transcranial Magnetic Stimulation to Treat Stuttering

Recruiting

Modulating Bilateral Cortical Activation In Adults Who Stutter: A Pilot Study

Who can join

Ages 18 to 65 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Age from 18 to 65 years
* Self-identifies as a person who currently stutters
* Right-handed or left-handed
* Normal hearing and (corrected) vision
* Able to understand and give informed consent
* Monolingual English speaker

Exclusion Criteria:

* Cardiac pacemaker or pacemaker wires; neurostimulators; implanted pumps
* Metal in the body (rods, plates, screws, shrapnel, dentures, IUD) or metallic particles in the eye
* Facial tattoos
* Not having medical insurance
* Surgical clips in the head or previous neurosurgery
* Any magnetic particles in the body
* Cochlear implants
* Prosthetic heart valves
* Epilepsy or any other type of seizure history
* History of significant head trauma (i.e., extended loss of consciousness, neurological sequelae)
* Known structural brain lesions
* Pre-existing speech, language, or neurological disorder (except for stuttering)
* Significant other disease (heart disease, malignant tumors, mental disorders)
* Significant claustrophobia; Ménière's disease
* Women who are trying to get pregnant and sexually active women (of reproductive age) not on a reliable contraceptive
* Pregnancy, breastfeeding
* Medications increasing the risk for seizures
* Non-prescribed drug use
* Use of recreational drugs such as medical marijuana
* Failure to perform the behavioral tasks or neuropsychological evaluation tests
* Prisoners

About the study

The goal of this clinical trial is to learn if repeated transcranial magnetic stimuli (rTMS) can treat stuttering in adults. The main questions it aims to answer are:

* Will there be changes in the brains of people who stutter because of the treatment? * Will any changes in the brain result in less stuttering?

Participants will:

* Visit the lab 3 times before treatment for tests * Complete 10 rTMS sessions * Visit the lab 2 times after treatment for tests

What is being tested

Sponsor: Kansas State University · Participants: 10 · Started: Feb 15, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07389694

Locations in the U.S.

KansasBluemont Hall, Department of Psychological Sciences, Kansas State University, Manhattan

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.